You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

List of Excipients in API emtricitabine, rilpivirine and tenofovir disoproxil fumarate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing emtricitabine, rilpivirine and tenofovir disoproxil fumarate

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801	CELLULOSE, MICROCRYSTALLINE
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801	CROSCARMELLOSE SODIUM
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801	LACTOSE MONOHYDRATE
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801	MAGNESIUM STEARATE
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801	POLYETHYLENE GLYCOL 3350
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801	POLYSORBATE 20
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for emtricitabine, rilpivirine and tenofovir disoproxil fumarate

Excipient focus: CELLULOSE, MICROCRYSTALLINE

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 3350

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 20

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing POLYSORBATE 20

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing POLYSORBATE 20

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing POVIDONE K30

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing POVIDONE K30

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Laurus Labs Limited	emtricitabine, rilpivirine and tenofovir disoproxil fumarate	42385-801
>Company	>Ingredient	>NDC

emtricitabine, rilpivirine and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.